These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24316107)

  • 1. Discovery and development of antisecretory drugs for treating diarrheal diseases.
    Thiagarajah JR; Ko EA; Tradtrantip L; Donowitz M; Verkman AS
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):204-9. PubMed ID: 24316107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chloride channel-targeted therapy for secretory diarrheas.
    Thiagarajah JR; Verkman AS
    Curr Opin Pharmacol; 2013 Dec; 13(6):888-94. PubMed ID: 23992767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide inhibitors of chloride channels for treating secretory diarrhea.
    Ma J; Ding X; Yin Y; Huang P
    Front Biosci (Landmark Ed); 2018 Jun; 23(10):1780-1788. PubMed ID: 29772528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CFTR inhibitors for treating diarrheal disease.
    Thiagarajah JR; Verkman AS
    Clin Pharmacol Ther; 2012 Sep; 92(3):287-90. PubMed ID: 22850599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CFTR pharmacology and its role in intestinal fluid secretion.
    Thiagarajah JR; Verkman AS
    Curr Opin Pharmacol; 2003 Dec; 3(6):594-9. PubMed ID: 14644010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-sensing receptor activator cinacalcet for treatment of cyclic nucleotide-mediated secretory diarrheas.
    Chu T; Yottasan P; Goncalves LS; Oak AA; Lin R; Tse M; Donowitz M; Cil O
    Transl Res; 2024 Jan; 263():45-52. PubMed ID: 37678755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CFTR chloride channel drug discovery--inhibitors as antidiarrheals and activators for therapy of cystic fibrosis.
    Verkman AS; Lukacs GL; Galietta LJ
    Curr Pharm Des; 2006; 12(18):2235-47. PubMed ID: 16787252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of CFTR-mediated intestinal chloride secretion by a fungus-derived arthropsolide A: Mechanism of action and anti-diarrheal efficacy.
    Akrimajirachoote N; Satitsri S; Sommart U; Rukachaisirikul V; Muanprasat C
    Eur J Pharmacol; 2020 Oct; 885():173393. PubMed ID: 32712094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzopyrimido-pyrrolo-oxazine-dione CFTR inhibitor (R)-BPO-27 for antisecretory therapy of diarrheas caused by bacterial enterotoxins.
    Cil O; Phuan PW; Gillespie AM; Lee S; Tradtrantip L; Yin J; Tse M; Zachos NC; Lin R; Donowitz M; Verkman AS
    FASEB J; 2017 Feb; 31(2):751-760. PubMed ID: 27871064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory diarrhoea: mechanisms and emerging therapies.
    Thiagarajah JR; Donowitz M; Verkman AS
    Nat Rev Gastroenterol Hepatol; 2015 Aug; 12(8):446-57. PubMed ID: 26122478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a novel chalcone derivative inhibiting CFTR chloride channel via AMPK activation and its anti-diarrheal application.
    Yibcharoenporn C; Chusuth P; Jakakul C; Rungrotmongkol T; Chavasiri W; Muanprasat C
    J Pharmacol Sci; 2019 Jul; 140(3):273-283. PubMed ID: 31444000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidiarrheal efficacy and cellular mechanisms of a Thai herbal remedy.
    Tradtrantip L; Ko EA; Verkman AS
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2674. PubMed ID: 24551253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances and new perspectives in targeting CFTR for therapy of cystic fibrosis and enterotoxin-induced secretory diarrheas.
    Zhang W; Fujii N; Naren AP
    Future Med Chem; 2012 Mar; 4(3):329-45. PubMed ID: 22393940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol dimer trans-ε-viniferin prevents rotaviral diarrhea in mice by inhibition of the intestinal calcium-activated chloride channel.
    Yu B; Jiang Y; Zhang B; Yang H; Ma T
    Pharmacol Res; 2018 Mar; 129():453-461. PubMed ID: 29155014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing novel antisecretory drugs to treat infectious diarrhea.
    de Hostos EL; Choy RK; Nguyen T
    Future Med Chem; 2011 Aug; 3(10):1317-25. PubMed ID: 21859305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crofelemer, an antisecretory antidiarrheal proanthocyanidin oligomer extracted from Croton lechleri, targets two distinct intestinal chloride channels.
    Tradtrantip L; Namkung W; Verkman AS
    Mol Pharmacol; 2010 Jan; 77(1):69-78. PubMed ID: 19808995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sesquiterpene lactones improve secretory diarrhea symptoms by inhibiting intestinal Ca
    Qu C; Guan X; Li C; Zhu X; Ma T; Li H; Yu B; Yang H
    Eur J Pharmacol; 2023 Sep; 955():175917. PubMed ID: 37473982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal epithelial potassium channels and CFTR chloride channels activated in ErbB tyrosine kinase inhibitor diarrhea.
    Duan T; Cil O; Thiagarajah JR; Verkman AS
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30668547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crofelemer: In HIV Associated Diarrhea and Secretory Diarrhea - A Patent Perspective.
    Biswal S
    Recent Pat Antiinfect Drug Discov; 2014; 9(2):136-43. PubMed ID: 25851117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fungal metabolite zearalenone as a CFTR inhibitor and potential therapy of secretory diarrheas.
    Muangnil P; Satitsri S; Tadpetch K; Saparpakorn P; Chatsudthipong V; Hannongbua S; Rukachaisirikul V; Muanprasat C
    Biochem Pharmacol; 2018 Apr; 150():293-304. PubMed ID: 29475061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.